Medical Condition News

RSS

Findings suggest usage of statins after surgery may reduce risk of prostate cancer recurrence

Men who begin taking statins after prostate cancer surgery are less likely to have a recurrence of their cancer, according to a retrospective analysis led by researchers at Duke Medicine.

2 May 2014

3 rules of thumb to reduce childhood obesity

Kristopher Kaliebe, MD, Clinical Assistant Professor of Psychiatry at the LSU Health Sciences Center New Orleans School of Medicine, offers parents and caregivers three simple family-oriented goals to overcome the complex problem of childhood obesity and related mental disorders.

2 May 2014

Study investigates how nanoparticles could be used to improve diagnosis, treatment of cardiovascular disease

A study to investigate how nanoparticles could be used to improve the diagnosis and treatment of cardiovascular disease has received -3 million funding.

2 May 2014

LUNGevity Foundation welcomes FDA approval of Zykadia drug for advanced stages of lung cancer

LUNGevity Foundation applauds the FDA approval of Zykadia™ for the subset of anaplastic lymphoma kinase-positive (ALK+) patients with advanced cases of non-small cell lung cancer who have progressed on or are intolerant to crizotinib.

2 May 2014

Custom-made mouthguards outperform store-bought models in reducing risk of concussion in athletes

When it comes to buying a mouthguard, parents who want to reduce their child's risk of a sports-related concussion should visit a dentist instead of a sporting goods store.

2 May 2014

Study shows noncombat-related injury are leading causes of in-hospital admissions for children in Iraq, Afghanistan

Noncombat-related injury-caused by regular car accidents, falls and burns-is the most common reason for pediatric admissions to U.S. military combat hospitals in both Iraq and Afghanistan reveals new study findings published in the May issue of the Journal of the American College of Surgeons.

2 May 2014

Virginia researchers develop new combination therapy that could potentially treat multiple myeloma

Each year, more than 25,000 Americans are diagnosed with multiple myeloma, a form of blood cancer that often develops resistance to therapies.

2 May 2014

$RTOG 9003: Hyperfractionated RT improves overall survival in patients with head and neck cancer$

RTOG 9003: Hyperfractionated RT improves overall survival in patients with head and neck cancer

Patients with locally advanced squamous cell carcinoma of the head and neck treated with hyperfractionated radiation therapy (HFX) experienced improved local-regional control and, with patients censored at five years, improved overall survival with no increase in late toxicity, according to a study published in the May 1, 2014 edition of the International Journal of Radiation Oncology ● Biology ● Physics (Red Journal), the official scientific journal of the American Society for Radiation Oncology (ASTRO).

2 May 2014

Scientists develop experimental drug that prolongs lifespan in mouse model of accelerated aging

Northwestern Medicine- scientists have newly identified a protein's key role in cell and physiological aging and have developed - in collaboration with Tohoku University in Japan -- an experimental drug that inhibits the protein's effect and prolonged the lifespan in a mouse model of accelerated aging.

2 May 2014

UT Southwestern docs receive grants for innovative studies on lung cancer pathways, drug therapy

Two UT Southwestern doctors have received more than a half-million dollars in grants from the Department of Defense for innovative studies on lung cancer pathways and to test the effectiveness of a potentially less expensive drug therapy.

2 May 2014

Scientists receive $2.3M grant to develop new technology to diagnose cancer, rheumatoid arthritis and colitis

Scientists from the Florida campus of The Scripps Research Institute (TSRI) have been awarded a $2.3 million grant from the National Institute of General Medical Sciences of the National Institutes of Health to develop new technology to diagnose cancer, rheumatoid arthritis and colitis.

2 May 2014

Genzyme, Cleveland Clinic partner to develop new therapeutic approaches for MS treatment

Genzyme, a Sanofi company, announced today the formation of a research collaboration with Cleveland Clinic focused on developing new therapeutic approaches to the treatment of MS.

30 Apr 2014

Restoring vision in patients with retinitis pigmentosa: an interview with Dr. Gregoire Cosendai, Vice President, Europe, Second Sight

Retinitis pigmentosa (RP) is a progressive eye disease that leads to untreatable blindness. The name of the disease derives from the fact that one of the areas affected by the disease is the retinal pigment epithelium (RPE) in the back of the eye.

30 Apr 2014

Teva announces positive results from pivotal Phase III study of hydrocodone bitartrate extended-release tablets

Teva Pharmaceutical Industries Ltd. today announced positive results from a pivotal Phase III study of hydrocodone bitartrate extended-release tablets designed with Teva's proprietary technology providing potential abuse-deterrent properties (CEP-33237).

30 Apr 2014

Purdue Pharma seeks FDA authorization to market once-daily hydrocodone bitartrate tablet

Purdue Pharma L.P. announced that it has filed a New Drug Application (NDA) with the U.S. Food & Drug Administration seeking authorization to market a once-daily, single-entity hydrocodone bitartrate tablet (HYD).

30 Apr 2014

Sheffield professor awarded prestigious Camillo Golgi Prize for outstanding contribution to medicine

A CONSULTANT who first described how diabetic nerve damage is caused by impaired circulation of the nerves has been awarded one of the most coveted international prizes in medicine in recognition of his outstanding contribution to the field.

30 Apr 2014

FAM hosts 13th annual event at Webber Cancer Center to benefit patients with fibromyalgia

The Fibromyalgia Association of Michigan (FAM) will host its 13th annual event at the Webber Cancer Center at St. John Macomb-Oakland Hospital on 11800 12 Mile Road from 12:30 - 5:30 PM.

30 Apr 2014

Research helps unpick long-standing mystery about how dietary fibre supresses appetite

New research has helped unpick a long-standing mystery about how dietary fibre supresses appetite. In a study led by Imperial College London and the Medical Research Council (MRC), an international team of researchers identified an anti-appetite molecule called acetate that is naturally released when we digest fibre in the gut.

30 Apr 2014

Synergy reports positive top-line results from plecanatide phase 2b study in patients with IBS-C

Synergy Pharmaceuticals Inc. today announced positive top-line results from a phase 2b dose-ranging study assessing plecanatide's safety and efficacy in 424 patients with irritable bowel syndrome with constipation (IBS-C).

30 Apr 2014

RDT receives FDA approval for new liquid form of treatment for patients with ALL

Rare Disease Therapeutics, Inc. (RDT), the producer of orphan pharmaceuticals for the treatment of rare diseases, announced today that they have received FDA approval for PURIXAN™ (mercaptopurine) 20 mg/mL oral suspension---a new, easier-to-dose, liquid form of an established treatment for patients with Acute Lymphoblastic Leukemia (ALL).

30 Apr 2014

Medical Condition News

Findings suggest usage of statins after surgery may reduce risk of prostate cancer recurrence

3 rules of thumb to reduce childhood obesity

Study investigates how nanoparticles could be used to improve diagnosis, treatment of cardiovascular disease

LUNGevity Foundation welcomes FDA approval of Zykadia drug for advanced stages of lung cancer

Custom-made mouthguards outperform store-bought models in reducing risk of concussion in athletes

Study shows noncombat-related injury are leading causes of in-hospital admissions for children in Iraq, Afghanistan

Virginia researchers develop new combination therapy that could potentially treat multiple myeloma

RTOG 9003: Hyperfractionated RT improves overall survival in patients with head and neck cancer

Scientists develop experimental drug that prolongs lifespan in mouse model of accelerated aging

UT Southwestern docs receive grants for innovative studies on lung cancer pathways, drug therapy

Scientists receive $2.3M grant to develop new technology to diagnose cancer, rheumatoid arthritis and colitis

Genzyme, Cleveland Clinic partner to develop new therapeutic approaches for MS treatment

Restoring vision in patients with retinitis pigmentosa: an interview with Dr. Gregoire Cosendai, Vice President, Europe, Second Sight

Teva announces positive results from pivotal Phase III study of hydrocodone bitartrate extended-release tablets

Purdue Pharma seeks FDA authorization to market once-daily hydrocodone bitartrate tablet

Sheffield professor awarded prestigious Camillo Golgi Prize for outstanding contribution to medicine

FAM hosts 13th annual event at Webber Cancer Center to benefit patients with fibromyalgia

Research helps unpick long-standing mystery about how dietary fibre supresses appetite

Synergy reports positive top-line results from plecanatide phase 2b study in patients with IBS-C

RDT receives FDA approval for new liquid form of treatment for patients with ALL

Exploring the nanoscale: How AFM is transforming cosmetic science

Innovating Texture and Culture in Plant-Based Foods

Advancing brain microphysiological systems (bMPS)

Latest News